SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-297915
Filing Date
2021-10-13
Accepted
2021-10-13 17:01:56
Documents
14
Period of Report
2021-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d237076d8k.htm   iXBRL 8-K 23832
2 EX-99.1 d237076dex991.htm EX-99.1 4928
6 GRAPHIC g237076sp-4.jpg GRAPHIC 2637
  Complete submission text file 0001193125-21-297915.txt   156929

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA chrs-20211008.xsd EX-101.SCH 2890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20211008_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20211008_pre.xml EX-101.PRE 11407
7 EXTRACTED XBRL INSTANCE DOCUMENT d237076d8k_htm.xml XML 3368
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 211321785
SIC: 2836 Biological Products, (No Diagnostic Substances)